495 related articles for article (PubMed ID: 30453459)
21. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
Wang P; Shi YH; Li JY; Zhang CZ
World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
[TBL] [Abstract][Full Text] [Related]
22. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
Bao S; Watanabe Y; Takahashi H; Tanaka H; Arisawa A; Matsuo C; Wu R; Fujimoto Y; Tomiyama N
Magn Reson Med Sci; 2019 Jan; 18(1):53-61. PubMed ID: 29848919
[TBL] [Abstract][Full Text] [Related]
23. Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
Hatakeyama J; Ono T; Takahashi M; Oda M; Shimizu H
Neurol Med Chir (Tokyo); 2021 Jun; 61(6):367-375. PubMed ID: 33967177
[TBL] [Abstract][Full Text] [Related]
24. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
[TBL] [Abstract][Full Text] [Related]
25. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
Abdel Razek AAK; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
World Neurosurg; 2019 Mar; 123():e303-e309. PubMed ID: 30502475
[TBL] [Abstract][Full Text] [Related]
27. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
Xia W; Hu B; Li H; Geng C; Wu Q; Yang L; Yin B; Gao X; Li Y; Geng D
J Magn Reson Imaging; 2021 Jan; 53(1):242-250. PubMed ID: 32864825
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative Flow Cytometry Enables the Differentiation of Primary Central Nervous System Lymphoma from Glioblastoma.
Koriyama S; Nitta M; Shioyama T; Komori T; Maruyama T; Kawamata T; Muragaki Y
World Neurosurg; 2018 Apr; 112():e261-e268. PubMed ID: 29330078
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
[TBL] [Abstract][Full Text] [Related]
30. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques.
Bathla G; Priya S; Liu Y; Ward C; Le NH; Soni N; Maheshwarappa RP; Monga V; Zhang H; Sonka M
Eur Radiol; 2021 Nov; 31(11):8703-8713. PubMed ID: 33890149
[TBL] [Abstract][Full Text] [Related]
31. Balanced transformer: efficient classification of glioblastoma and primary central nervous system lymphoma.
Wang S; Wu J; Chen M; Huang S; Huang Q
Phys Med Biol; 2024 Feb; 69(4):. PubMed ID: 38232389
[No Abstract] [Full Text] [Related]
32. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
33. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T
Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of Primary Central Nervous System Lymphoma and High-Grade Glioma with Dynamic Susceptibility Contrast-Derived Metrics: Pilot Study.
Chaganti J; Taylor M; Woodford H; Steel T
World Neurosurg; 2021 Jul; 151():e979-e987. PubMed ID: 34020062
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
Ohno M; Matsuzaki J; Kawauchi J; Aoki Y; Miura J; Takizawa S; Kato K; Sakamoto H; Matsushita Y; Takahashi M; Miyakita Y; Ichimura K; Narita Y; Ochiya T
JAMA Netw Open; 2019 Dec; 2(12):e1916953. PubMed ID: 31808923
[TBL] [Abstract][Full Text] [Related]
36. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
[TBL] [Abstract][Full Text] [Related]
37. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
[TBL] [Abstract][Full Text] [Related]
38. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Hata N; Akagi Y; Suzuki SO; Iwaki T; Iihara K; Honda H
Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
[TBL] [Abstract][Full Text] [Related]
39. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
Kawai N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
[TBL] [Abstract][Full Text] [Related]
40. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
